CliffBio

Eisai

Patent cliffs & loss of exclusivity

Small Molecules

Company

AngelList URLhttps://angel.co/company/eisai-pharmaceuticals
CAGE CodeSYC66
Legal NameEisai Co., Ltd.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/eisai-co
Facebook URLhttps://m.facebook.com/Eisaimexico/
Fax Number1-201-746-2600
Full Address200 Metro Blvd, Nutley, New Jersey 07110, U.S.A.

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. ARICEPTDONEPEZIL HYDROCHLORIDESmall mol.Oct 2026
  2. HALAVENERIBULIN MESYLATESmall mol.Jul 2027
  3. DAYVIGOLEMBOREXANTSmall mol.Oct 2035
  4. DAYVIGOLEMBOREXANTSmall mol.Oct 2035
  5. LENVIMALENVATINIB MESYLATESmall mol.Nov 2038
  6. LENVIMALENVATINIB MESYLATESmall mol.Nov 2038
  7. HEXALENALTRETAMINESmall mol.—
  8. LUSEDRAFOSPROPOFOL DISODIUMSmall mol.—
  9. ARICEPTDONEPEZIL HYDROCHLORIDESmall mol.—
  10. BANZELRUFINAMIDESmall mol.—
  11. ARICEPT ODTDONEPEZIL HYDROCHLORIDESmall mol.—
  12. ARICEPT ODTDONEPEZIL HYDROCHLORIDESmall mol.—
  13. ARICEPTDONEPEZIL HYDROCHLORIDESmall mol.—
  14. ARICEPTDONEPEZIL HYDROCHLORIDESmall mol.—
  15. BANZELRUFINAMIDESmall mol.—
  16. BANZELRUFINAMIDESmall mol.—
  17. BANZELRUFINAMIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.